State University of New York (SUNY)·New York

Bio Rad Immunology and Molecular Control Products

Closes 6/2/2026$500k – $2.5MSole SourceLogin required

Bid source

Description

NYS Contract Reporter Exemption Request # SNY01-0004499-3320215(CRER-0455C) - Approved by OSC on 5/08/2026

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

Marilou Ferrara(Procurement Officer II)

[email protected]

(631) 444-4055

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+

bids & awards

All 50

states

4,000+

agencies

Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

Learn more

More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →

Description

Attached files

Contact

Similar opportunities

You found this one too late. Don't find the next one too late.

Learn more

Description

Attached files

Contact

Similar opportunities

Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories

6550--Blood Type IVD Reagents

Reagents and consumables for Roche immunostainers

Early Detection, Response, and Control of Global Rabies Outbreaks and Associated Threats to America's Dog-Rabies Free Status

Non-Optical Methods for High Speed Protein Control

BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB

6550--Blood Bank Reagents

Pre-Clinical Models of Infectious Diseases

TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform

2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases

Discovery and Development of Small Molecules and Biologic Therapies RFP

Fiscal Year 2026 BioWatch Grant Program

Alternative Protein Technologies for Military Field Feeding

RNomics Molecular Standards

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

BROAD AGENCY ANNOUNCEMENT (BAA) FOR CHEMICAL BIOLOGICAL RADIOLOGICAL NUCLEAR AND EXPLOSIVE (CBRNE) DEFENSE EFFORTS UNDER PROCUREMENT CONTRACTS, COOPERATIVE AGREEMENTS, AND PROTOTYPES UNDER OTHER TRANSACTIONS AGREEMENTS

81627Y0875-Purchase of Raboravel V-RG Vaccines

TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform

Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)

Microbial Identification System (MIS)

TECHNOLOGY LICENSING OPPORTUNITY: DC Recruiter

Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)

Individual Water Treatment Device (IWTD) for Reduction/Removal of Toxic Industrial Chemicals and Materials

TECHNOLOGY LICENSING OPPORTUNITY: NanoFET

RNA sequencing and whole genome sequencing services

You found this one too late. Don't find the next one too late.

Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories

6550--Blood Type IVD Reagents

Reagents and consumables for Roche immunostainers

Early Detection, Response, and Control of Global Rabies Outbreaks and Associated Threats to America's Dog-Rabies Free Status

Non-Optical Methods for High Speed Protein Control

BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB

6550--Blood Bank Reagents

Pre-Clinical Models of Infectious Diseases

TECHNOLOGY LICENSING OPPORTUNITY: Bacterial Lipid Nanodiscs Platform

2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases

Discovery and Development of Small Molecules and Biologic Therapies RFP

Fiscal Year 2026 BioWatch Grant Program

Alternative Protein Technologies for Military Field Feeding

RNomics Molecular Standards

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

BROAD AGENCY ANNOUNCEMENT (BAA) FOR CHEMICAL BIOLOGICAL RADIOLOGICAL NUCLEAR AND EXPLOSIVE (CBRNE) DEFENSE EFFORTS UNDER PROCUREMENT CONTRACTS, COOPERATIVE AGREEMENTS, AND PROTOTYPES UNDER OTHER TRANSACTIONS AGREEMENTS

81627Y0875-Purchase of Raboravel V-RG Vaccines

TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics Platform

Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)

Microbial Identification System (MIS)

TECHNOLOGY LICENSING OPPORTUNITY: DC Recruiter

Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed)

Individual Water Treatment Device (IWTD) for Reduction/Removal of Toxic Industrial Chemicals and Materials

TECHNOLOGY LICENSING OPPORTUNITY: NanoFET

RNA sequencing and whole genome sequencing services